Ravelcare schedules AGM for September 23 to approve director reappointments

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Ravelcare schedules 8th AGM for September 23, 2026, via Video Conferencing
  • Agenda includes reappointment of MD Ayush Varma and WTD Maheshkumar Varma
  • FY26 revenue rose 7.9% to ₹2,695.43 lakhs; PAT increased 1.3% to ₹515.40 lakhs
  • Company remains debt-free with net worth of ₹3,740.84 lakhs
  • No dividend proposed for FY26; funds preserved for manufacturing integration
powered bylight_fuzz_icon
49305476

*this image is generated using AI for illustrative purposes only.

Ravelcare has scheduled its 8th Annual General Meeting (AGM) for Wednesday, September 23, 2026, at 11:30 am via Video Conferencing. The meeting agenda includes the reappointment of key directors and the adoption of audited financial statements for FY26.

Corporate Governance Updates

Shareholders will vote on the reappointment of Mr. Ayush Varma as Managing Director for a further period of three years, effective June 20, 2027. His remuneration is capped at ₹75 lakhs per annum. The Board also seeks approval for the reappointment of Mr. Maheshkumar Varma as Whole-time Director for three years, with remuneration up to ₹30 lakhs per annum.

Additionally, Mrs. Anita Mahesh Varma retires by rotation and offers herself for reappointment as Non-Executive Director. The cut-off date for determining shareholder eligibility for voting is September 16, 2026. Remote e-voting will commence on September 20, 2026, at 9:00 am and end on September 22, 2026, at 5:00 pm.

FY26 Financial Performance

For the fiscal year ended March 31, 2026, Ravelcare reported revenue from operations of ₹2,695.43 lakhs, a 7.9% increase over the previous year. Profit after tax stood at ₹515.40 lakhs, representing a net profit margin of 19.1%. The company remains debt-free with a net worth of ₹3,740.84 lakhs.

Metric FY26 Value YoY Change
Revenue ₹2,695.43 lakhs +7.9%
Profit After Tax ₹515.40 lakhs +1.3%
Net Worth ₹3,740.84 lakhs N/A

Other income declined to ₹8.29 lakhs from ₹31.91 lakhs in the prior year. Total expenses rose to ₹1,996.47 lakhs from ₹1,826.44 lakhs. The Board did not propose any dividend for FY26, opting to preserve resources for growth initiatives.

Product Expansion and Strategy

The company launched Ravel PRO, a clinical haircare line, in June 2026. This range targets specific concerns such as hair fall and dandruff and is available across major e-commerce and quick-commerce platforms. Two additional PRO products are scheduled for launch in September 2026.

Management plans to launch an AI-led diagnostic skincare range in the second half of FY27. Funds from the December 2025 IPO, which raised ₹2,410.20 lakhs, remain largely unutilised and are held in bank fixed deposits. These funds are earmarked for backward integration into manufacturing and general corporate purposes.

Historical Stock Returns for Ravelcare

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%-9.80%-30.83%-47.47%-47.47%

How will the upcoming launch of the AI-led diagnostic skincare range in H2 FY27 impact Ravelcare's revenue diversification and competitive positioning against established dermatological brands?

Given that IPO proceeds are currently held in fixed deposits, what is the specific timeline and strategic roadmap for deploying these funds into backward integration and manufacturing capabilities?

With net profit growth lagging behind revenue growth in FY26, what operational efficiencies or cost-control measures are management planning to implement to improve margins in the coming fiscal year?

Ravelcare reappoints Ayush Varma, Maheshkumar Varma as directors

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Ayush Varma reappointed as Managing Director for a three-year term starting June 20, 2027
  • Maheshkumar Varma reappointed as Whole-time Director for a three-year term starting June 20, 2027
  • Registered office shifted to new location in Malad West, Mumbai, effective August 26, 2026
  • VTSN & Associates LLP appointed as Secretarial Auditor for FY27
powered bylight_fuzz_icon
49209220

*this image is generated using AI for illustrative purposes only.

Ravelcare Ltd board of directors approved the reappointment of key promoters and shifted its registered office during a meeting held on August 25, 2026. The decisions require shareholder approval at the upcoming annual general meeting.

The board, acting on recommendations from the Nomination and Remuneration Committee, renewed the mandates for Mr. Ayush Varma and Mr. Maheshkumar Varma. Both appointments are effective from June 20, 2027, through June 19, 2030.

Director Reappointments

Mr. Ayush Varma, aged 30, was reappointed as Managing Director. He holds a Bachelor of Technology degree in Computer Engineering from K.J. Somaiya College of Engineering. As a promoter and one of the first directors, he brings over six years of experience in the beauty and personal care industry. His responsibilities include business development, strategy formulation, and overseeing core business functions.

Mr. Maheshkumar Varma, aged 57, was reappointed as Whole-time Director. He completed his Higher Secondary Certificate Examination from Brijlal Biyani Science College, Amravati. He operates a proprietary firm named Madhuri Jewellers. At Ravelcare, he oversees strategic decisions, accounting, finance functions, and standard operating procedures.

The filing confirms that both directors are not debarred from holding office by any SEBI order or other authority, in compliance with SEBI guidelines dated June 14, 2018, and Exchange Circular dated June 20, 2018.

Director Role Term Start Term End Relation
Ayush Varma Managing Director June 20, 2027 June 19, 2030 Son of Maheshkumar Varma
Maheshkumar Varma Whole-time Director June 20, 2027 June 19, 2030 Father of Ayush Varma

Corporate Governance Updates

The Audit Committee recommended the appointment of M/s. VTSN & Associates LLP as Secretarial Auditors for the financial year 2026-27. The firm, registered with the Institute of Company Secretaries of India (ICSI), specializes in corporate laws, securities laws, and governance compliance.

Additionally, the board approved shifting the registered office within Mumbai’s jurisdiction. The new address is 12th Floor, Flat 1211, 9 Business Bay, Khakhar Property, Off New Link Road Mindspace, Behind Evershine Mall, Chincholi Bunder, Malad (W), Mumbai-400064. This change takes effect on August 26, 2026.

The board also issued the notice for the 8th Annual General Meeting along with the Directors Report for the year ended March 31, 2026. Mr. Vishal Thawani, Designated Partner of VTSN & Associates LLP, was appointed as Scrutinizer for the e-voting process.

Historical Stock Returns for Ravelcare

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%-9.80%-30.83%-47.47%-47.47%

How might the three-year tenure extension for the Varma family influence Ravelcare's strategic direction in the competitive beauty and personal care sector?

What operational or logistical advantages does the new registered office location in Malad (W) offer compared to the previous address?

Are there any specific governance reforms or compliance enhancements expected under the newly appointed Secretarial Auditor, VTSN & Associates LLP?

More News on Ravelcare

1 Year Returns:-47.47%